Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omega Therapeutics Inc (NQ: OMGA )

7.800 -0.160 (-2.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 114,947
Open 7.950
Bid (Size) 7.600 (1)
Ask (Size) 8.950 (8)
Prev. Close 7.960
Today's Range 7.505 - 8.817
52wk Range 1.975 - 11.98
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Analyst Ratings for Omega Therapeutics
 
Via Benzinga

Performance

YTD
+35.42%
+35.42%
1 Month
-3.82%
-3.82%
3 Month
+33.79%
+33.79%
6 Month
+16.42%
+16.42%
1 Year
+243.61%
+243.61%

More News

Read More
Omega Therapeutics: Q1 Earnings Insights
Via Benzinga
Omega Therapeutics Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
From Omega Therapeutics
Via GlobeNewswire
Omega Therapeutics to Present New Preclinical Data at the American Society of Clinical Oncology 2023 Annual Meeting
From Omega Therapeutics
Via GlobeNewswire
Analyst Expectations for Omega Therapeutics's Future
Via Benzinga
Omega Therapeutics Could Offer 'Intriguing' Liver Cancer Drug, Analyst Says
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Omega Therapeutics Announces Clinical Supply Agreement to Evaluate the Combination of OTX-2002 and Atezolizumab in Hepatocellular Carcinoma
From Omega Therapeutics
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Omega Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Omega Therapeutics
Via GlobeNewswire
Over $19M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Omega Therapeutics Announces $40 Million Registered Direct Offering of Common Stock
From Omega Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Omega Therapeutics to Present Trial-in-Progress Poster for Phase 1/2 MYCHELANGELO™ I Study at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
From Omega Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Up 50 Points; Gold Rises Over 1%
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2022
Via Benzinga
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.